Dwight D. Koeberl
18Patents
5h-index
16Co-inventors
63Inventor score
Filing activity: May 30, 2002 → May 22, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7858367B2 | Viral vectors and methods for producing and using the same | Chemistry; Metallurgy | 30 | Expired |
| US9186420B2 | Immunomodulating gene therapy | Chemistry; Metallurgy | 23 | Active |
| US10098905B2 | Immunomodulating gene therapy | Chemistry; Metallurgy | 8 | Active |
| US9873868B2 | Constructs for expressing lysosomal polypeptides | Chemistry; Metallurgy | 7 | Active |
| US8679478B2 | Methods of lysosomal storage disease therapy | Chemistry; Metallurgy | 5 | Active |
| US10940125B2 | Methods and compositions for the treatment of steatosis-associated disorders | Chemistry; Metallurgy | 5 | Active |
| US10869906B2 | Method of reducing titers of antibodies specific for a therapeutic agent | Chemistry; Metallurgy | 4 | Active |
| US6946126B2 | Replicating adenovirus vectors | Chemistry; Metallurgy | 3 | Expired |
| US9592247B2 | Method of reducing titers of antibodies specific for a therapeutic agent | Chemistry; Metallurgy | 3 | Active |
| US11421211B2 | Acid-alpha glucosidase variants and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11547717B2 | Immunomodulating gene therapy | Chemistry; Metallurgy | 3 | Active |
| US11690812B2 | Methods and compositions for the treatment of steatosis-associated disorders | Chemistry; Metallurgy | 3 | Active |
| US8809282B2 | Method of reducing titers of antibodies specific for a therapeutic agent | Chemistry; Metallurgy | 2 | Active |
| US11717560B2 | Compositions comprising nucleic acid molecules and methods of treating ATPase-mediated diseases | Chemistry; Metallurgy | 0 | Active |
| US12171731B2 | Methods and compositions for the treatment of steatosis-associated disorders | Chemistry; Metallurgy | 0 | Active |
| US12036190B2 | Methods and compositions for the treatment of cytoplasmic glycogen storage disorders | Chemistry; Metallurgy | 0 | Active |
| US10028993B2 | Method of reducing titers of antibodies specific for a therapeutic agent | Chemistry; Metallurgy | 0 | Active |
| US12290549B2 | Method of reducing titers of antibodies specific for a therapeutic agent | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.